Vitacon Health: Commercial Analytics for Life Sciences

Life Sciences Commercial Expertise for Investors

Vitacon seeks to assist investors in evaluating potential opportunities in the
biopharmaceutical space.

Uniquely poised at the intersection of strategic marketing and finance, our professionals are experts
in screening promising assets for investors. We provide bespoke research services in market sizing,
forecasting, deal analysis, and strategic landscape overview to our clients.

Vitacon specializes in working with private equity and hedge fund managers in
analyzing royalty streams of pharmaceutical assets.

Please see our Expertise section for more details.

NEW! Vitacon is proud to release its latest edition of business intelligence reports for
the Oncology therapeutic area. The reports, published quarterly, summarize ten of the
hottest drug candidate opportunities in early development for in-licensing or
acquisition. These reports are a must-have for remaining on top of this challenging and
fast-moving space. Please see our brochure for more information.

Vitacon Health